Cypress Biosciences, Inc.
|Cypress Biosciences, Inc. Patent applications|
|Patent application number||Title||Published|
|20090275562||TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATION - A reduction in the side effects of treating with an agent having combined 5HT||11-05-2009|
|20090270373||TREATMENT OF DOWN SYNDROM WITH BENZODIAZEPINE RECEPTOR ANTAGONISTS - Pharmaceutical compositions and methods of treating Down Syndrome, mental retardation or both are provided. The pharmaceutical compositions comprise one or more benzodiazepine receptor antagonists, such as flumazenil.||10-29-2009|
|20090048233||Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination - Provided are combinations of pharmaceutical agents capable of eliciting a therapeutic effect. A first therapeutic agent in the combination has 5HT||02-19-2009|